Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Dermatofibroma epidemiology and demographics
Introduction
Overview
Overview
Dermatofibroma is a common benign skin lesion that is seen in almost 3000 dermatophatology laboratory specimens per 100,000 ones. As most of patients with dermatofibroma are asymptomatic, the worldwide incidence of dermatofibroma is unknown. Patients of all age groups may develop dermatofibroma. Although, it is more occurred in 20s to 40s ages. There is no racial predilection to dermatofibroma. Female are more commonly affected by dermatofibroma than male. The female to male ratio is approximately 2 to 1.
Epidemiology
Epidemiology
Prevalence
- Dermatofibroma is a common benign skin lesion that is seen in almost 3000 dermatophatology laboratory specimens per 100,000 ones. [1][2]
Incidence
- As most of patients with dermatofibroma are asymptomatic, the worldwide incidence of dermatofibroma is unknown.[2][3]
Demographics
Demographics
Age
- Patients of all age groups may develop dermatofibroma. Although, it is more common in the 20s to 40s ages. [1][2][4]
Race
Gender
- Female are more commonly affected by dermatofibroma than male. The female to male ratio is approximately 2 to 1.[1][3][5][4]
Region
- The majority of [disease name] cases are reported in [geographical region].
- [Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].
References
References
- ↑ 1.0 1.1 1.2 1.3 Agarwal, Atin; Gopinath, Arun; Tetzlaff, Michael T.; Prieto, Victor G. (2017). “Phosphohistone-H3 and Ki67”. The American Journal of Dermatopathology. 39 (7): 504–507. doi:10.1097/DAD.0000000000000690. ISSN 0193-1091.
- ↑ 2.0 2.1 2.2 Buehler, Darya; Weisman, Paul (2017). “Soft Tissue Tumors of Uncertain Histogenesis”. Clinics in Laboratory Medicine. 37 (3): 647–671. doi:10.1016/j.cll.2017.06.005. ISSN 0272-2712.
- ↑ 3.0 3.1 3.2 Bandyopadhyay, MousumiRoy; Besra, Mrinal; Dutta, Somasree; Sarkar, Somnath (2016). “Dermatofibroma: Atypical presentations”. Indian Journal of Dermatology. 61 (1): 121. doi:10.4103/0019-5154.174131. ISSN 0019-5154.
- ↑ 4.0 4.1 Han, Tae Young; Chang, Hee Sun; Lee, June Hyun Kyung; Lee, Won-Mi; Son, Sook-Ja (2011). “A Clinical and Histopathological Study of 122 Cases of Dermatofibroma (Benign Fibrous Histiocytoma)”. Annals of Dermatology. 23 (2): 185. doi:10.5021/ad.2011.23.2.185. ISSN 1013-9087.
- ↑ Åženel, E.; Yuyucu Karabulut, Y.; DoÄŸruer Åženel, S. (2015). “Clinical, histopathological, dermatoscopic and digital microscopic features of dermatofibroma: a retrospective analysis of 200 lesions”. Journal of the European Academy of Dermatology and Venereology. 29 (10): 1958–1966. doi:10.1111/jdv.13092. ISSN 0926-9959.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2]